- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.10. | Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2026 | 170 | PR Newswire | STOCKHOLM, Oct. 22, 2025 /PRNewswire/ -- The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2026:
Anders... ► Artikel lesen | |
| 26.09. | SciBase: Nevisense Used in Fundamental Skin Barrier Research on Atopic Dermatitis | 279 | PR Newswire | STOCKHOLM, Sept. 26, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, announced today the publication... ► Artikel lesen | |
| 23.09. | SciBase receives initial order for clinical study from Castle Biosciences | 286 | PR Newswire | STOCKHOLM, Sept. 23, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that it has... ► Artikel lesen | |
| 10.09. | Main owners strengthen their position in SciBase | 284 | PR Newswire | STOCKHOLM, Sept. 10, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that Ribbskottet... ► Artikel lesen | |
| 28.08. | SciBase: New Clinical Publication in Karger Dermatology Confirms Reader Studies as Key to Validating Nevisense | 282 | PR Newswire | STOCKHOLM, Aug. 28, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces the recent publication... ► Artikel lesen | |
| SCIBASE Aktie jetzt für 0€ handeln | |||||
| 19.08. | SciBase: Interim report | 354 | PR Newswire | STOCKHOLM, Aug. 19, 2025 /PRNewswire/ --
January 1 - June 30, 2025
The second quarter in figures
Net sales were TSEK 8,791 (6,641), +32%, cleared for currency effects +40%.The... ► Artikel lesen | |
| 01.08. | SciBase announces outcome in directed share issue | 378 | PR Newswire | STOCKHOLM, Aug. 1, 2025 /PRNewswire/ -- On 16 June 2025, SciBase Holding AB (publ) ("SciBase" or the "Company") announced that the Company's Board of Directors resolved, pursuant to the authorisation... ► Artikel lesen | |
| 09.07. | SciBase Launches Nevisense Pilot at Leading University in Southeast Florida | 254 | PR Newswire | STOCKHOLM, July 9, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that a... ► Artikel lesen | |
| 07.07. | SciBase: A new important customer in the US, Palm Beach Dermatology Group, has placed an initial order for 6 Nevisense. | 305 | PR Newswire | STOCKHOLM, July 7, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, is pleased to announce... ► Artikel lesen | |
| 30.06. | SciBase announces outcome in directed share issue | 207 | PR Newswire | STOCKHOLM, June 30, 2025 /PRNewswire/ -- On 23 June 2025, SciBase Holding AB (publ) ("SciBase" or the "Company") announced that the Company's board of directors resolved, pursuant to the... ► Artikel lesen | |
| 23.06. | SciBase resolves on a directed share issue of approximately SEK 11 million | 338 | PR Newswire | STOCKHOLM, June 23, 2025 /PRNewswire/ -- The board of directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today, in accordance with the intention published by the Company... ► Artikel lesen | |
| 17.06. | Bulletin from the annual general meeting in SciBase Holding AB (publ) | 427 | PR Newswire | STOCKHOLM, June 17, 2025 /PRNewswire/ -- Today, the annual general meeting 2025 has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance... ► Artikel lesen | |
| 17.06. | SciBase has signed a Collaboration and License Agreement with Castle Biosciences to develop diagnostic tests within dermatology and intends to carry out a directed share issue of approximately MSEK 30 | 395 | PR Newswire | STOCKHOLM, June 17, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced it has signed... ► Artikel lesen | |
| 16.06. | Castle Biosciences partners with SciBase for diagnostic tests | 1 | Seeking Alpha | ||
| 16.06. | SciBase resolves on a directed share issue of SEK 19 million and announces its intention to carry out an additional directed share issue of approximately SEK 11 million | 453 | PR Newswire | STOCKHOLM, June 16, 2025 /PRNewswire/ -- The board of directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today, pursuant to the authorisation granted by the annual general... ► Artikel lesen | |
| 16.06. | Castle Biosciences partners with SciBase to develop atopic dermatitis test | 1 | Investing.com | ||
| 16.06. | Castle Biosciences, Inc.: Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases | 201 | GlobeNewswire (Europe) | FRIENDSWOOD, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it... ► Artikel lesen | |
| 09.06. | SciBase Initiates Self-Pay Model in the US to Make Nevisense Test More Accessible to Patients | 348 | PR Newswire | STOCKHOLM, June 9, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, today announced the launch... ► Artikel lesen | |
| 04.06. | SciBase Expands Further Through European Market with First Sales Order to customer in Italy | 261 | PR Newswire | STOCKHOLM, June 4, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, today announced its first... ► Artikel lesen | |
| 27.05. | SciBase reaches milestone with over 300,000 patients tested with Nevisense | 265 | PR Newswire | STOCKHOLM, May 27, 2025 /PRNewswire/ -- SciBase Holding AB ('SciBase') (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, today announced a major... ► Artikel lesen |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 92,49 | +0,05 % | Roku meldet starkes Q3: Streaming-Anbieter erzielt zweistelliges Umsatzwachstum und schwarze Zahlen | SAN JOSE, Kalifornien (IT-Times) - Roku, Anbieter von Hard- und Software für Video-Streaming-Services, hat seine Ergebnisse für das dritte Quartal 2025 veröffentlicht und ein zweistelliges Wachstum... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,090 | -4,76 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 85,80 | -0,46 % | Boston Scientific Sustains EP Momentum in Q3: Is More Upside Ahead? | ||
| PAUL HARTMANN | 223,00 | -1,76 % | Januar bis Juni 2025: PAUL HARTMANN behauptet sich in herausforderndem Marktumfeld | Heidenheim (ots) - - Umsatzerlöse steigen auf 1.214,0 Mio. EUR, organisches Umsatzwachstum von 1,6 % - Bereinigtes EBITDA liegt bei 125,8 Mio. EUR, bereinigte EBITDA-Rendite bei 10,4 % - Transformationsprogramm... ► Artikel lesen | |
| SYSMEX | 9,050 | -5,73 % | Comgest Growth Japan Fonds: Von Sysmex bis Obic - Comgest setzt auf Japans Qualitätstitel | Paris (www.fondscheck.de) - Japan ist "in", so Richard Kaye, Portfoliomanager für japanische Aktien bei der Fondsboutique Comgest im Kommentar zum Comgest Growth Japan Fonds (ISIN IE0004767087/ WKN... ► Artikel lesen | |
| ADDLIFE | 18,000 | -1,69 % | AddLife AB: Interim Report January 1 - September 30, 2025 | Good organic growth and strong earnings development"AddLife's companies performed strongly during the quarter. Organic growth was solid, margin improvement continued, earnings increased significantly... ► Artikel lesen | |
| EMBECTA | 11,700 | -0,85 % | Dividendenbekanntmachungen (29.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,34 USD 0,2911 EUR ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,18 USD 0,1541 EUR AEBI SCHMIDT HOLDING... ► Artikel lesen | |
| ENOVIS | 27,200 | -0,73 % | Enovis Corporation Q3 2025 Earnings Preview | ||
| KANGJI MEDICAL | 0,995 | 0,00 % | KANGJI MEDICAL (09997): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | ||
| PULMONX | 1,610 | +6,62 % | Pulmonx reports Q3 Preliminary results | ||
| KOOTH | 1,420 | 0,00 % | Kooth inks contract with New Jersey for further year under same terms | ||
| PEIJIA MEDICAL | 0,645 | +1,57 % | Peijia Medical Announces 2025 Interim Results | HONG KONG, Aug. 25, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets... ► Artikel lesen | |
| SI-BONE | 13,000 | +3,17 % | SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance | Second Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $48.6 million, representing growth of 21.7%U.S. revenue of $46.4 million, representing... ► Artikel lesen | |
| LIFECARE ASA | 0,467 | 0,00 % | Lifecare ASA: Lifecare shares key learnings from ongoing longevity study LFC-SEN-002 | ||
| BACTIGUARD | 1,320 | -5,71 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report third quarter 2025 | Continued profitability and clinical evidence supporting future growth
Third quarter 2025 (July - September)
Total revenue amounted to SEK 48.4 (73.9) million, a decrease of SEK 25.5 million corresponding... ► Artikel lesen |
SCIBASE HOLDING AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,002 (-40,91 %) liegt der Kurs bei 0,003 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCIBASE HOLDING AB finden Sie auf Wallstreet Online.